Mage Biologics announces first subject dosed in a Phase 1 trial with MB-001, an orally administered antibody for Inflammatory Bowel Disease
June 12, 2024
June 12, 2024
June 11, 2024
June 6, 2024
June 5, 2024
May 29, 2024
May 29, 2024
May 22, 2024
May 15, 2024
May 15, 2024
September 3, 2025
EpiCypher®, a pioneer in epigenomic research and technology, announces the launch of CUTANA® Fiber-seq, a groundbreaking multiomic genomics platform t...
August 28, 2025
Accelerated platform delivers validated biomarkers with ready-to-use Optimer ligands in months rather than years Biomarkers are identified based on th...
August 20, 2025
MMS, a global, data-focused clinical research organization (CRO), announced today that it has been chosen by Friends of Cancer Research (Friends), a l...
Life Science Newswire is a division of BioStrata Ltd, with company registered address: 3rd Floor, 1 Ashley Road, Altrincham, Cheshire, England, WA14 2DT. Company registration number: 8233225